Recital 6, Decision_act (EU) 2018/9019

In forcesince 29 Oct 2018

Pursuant to a sale purchase agreement entered into on 7 June 2018 between Mars

(as buyer) and Nordic Capital, Fidelio Capital and other minority shareholders of AniCura (as sellers), Mars will acquire 100% of the issued and to be issued share capital in AniCura.